NCT04125784
- Conditions
- Blood-Borne Infections, Cardiovascular Risk Factor, Communicable Diseases, +20 more
- Locations
-
- Schalk:Pichler Gruppenpraxis Vienna, Austria
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
8,024 public trials
710 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT05789706
- Conditions
- Diabete Type 2, Diabetes, Diabetes Mellitus, +5 more
- Locations
-
- VA Sierra Nevada Health Care System Reno, Nevada, United States
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novo Nordisk Investigational Site Manama, Bahrain
- Novo Nordisk Investigational Site Alexandria, Egypt
- Novo Nordisk Investigational Site Amman, Jordan
- Novo Nordisk Investigational Site As Sālimīyah, Kuwait
NCT04083820
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novo Nordisk Investigational Site Angers, France
- Novo Nordisk Investigational Site Annecy, France
- Novo Nordisk Investigational Site Auffay, France
- Novo Nordisk Investigational Site Avignon, France
NCT05787067
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- Atatürk Universty Erzurum, Turkey (Türkiye)
NCT04261933
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novo Nordisk Investigational Site Amberg, Germany
- Novo Nordisk Investigational Site Aschaffenburg, Germany
- Novo Nordisk Investigational Site Augsburg, Germany
- Novo Nordisk Investigational Site Bad Mergentheim, Germany
NCT03322631
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Hachiōji, Tokyo, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Shinjuku-Ku, Tokyo, Japan
NCT05328726
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Celerion Lincoln, Nebraska, United States
Completed
SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
NCT05782192
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- 1. Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Completed
Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial
NCT03871621
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Mackay Memorial Hospital Taipei, Taiwan